Metformin increases the plasma level of glucagon-like peptide-1 (GLP-1) and does not inhibit dipeptidyl peptidase-IV

By  

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Cardiovascular Effects of Glucagon-Like Peptide 1

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. : 97-105

Bentham Science Publishers

Access to resources Recommend Favorite

NN2211: a long-acting glucagon-like peptide-1 derivative with anti-diabetic effects in glucose-intolerant pigs

By Ribel U.   Larsen M.O.   Rolin B.   Carr R.D.   Wilken M.   Sturis J.   Westergaard L.   Deacon C.F.   Knudsen L.B.  

European Journal of Pharmacology, Vol. 451, Iss. 2, 2002-09 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

Role of glucagon-like peptide-1 analogues on insulin receptor regulation in diabetic rat hearts

By Hantouche Christine M.   Bitar Khalil M.   Nemer Georges M.   Obeid Mounir Y.   Kadi Lina N.   Der-Boghossian Asdghig H.   Bikhazi Anwar B.  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 1, 2010-01 ,pp. : 54-63

NRC Research Press

Access to resources Recommend Favorite

Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2

By Brubaker Patricia L   Anini Younes  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 11, 2003-11 ,pp. : 1005-1012

NRC Research Press

Access to resources Recommend Favorite